Danaher shared its plan for growth at the UBS Global Healthcare Conference, aiming for more market share and new ideas.

Nov 9, 2026, 10:16 PM ETOpinionRead the original at tradingview.com

Good for DHR

Danaher aims to gain market share and expects reshoring to add sales from 2028. These plans support growth, but the added sales have not started yet.

DHR · Danaher Corporation

AI read · Good for DHR

The AI's read

Winning more customers and selling more products to current customers could help Danaher grow its diagnostics and life sciences businesses. Reshoring may add another source of sales, but the company expects that to start only in 2028. These are plans, not reported results.

Get alerts for DHR

Follow Danaher Corporation (DHR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DHR

Free on the App Store and Google Play, or on the web.